To our knowledge, no studies have investigated the role of DNA methylation alterations in PHLDA2 dysregulation in cancers, except for one study conducted by Fu and colleagues, which revealed that DNA methylation status of PHLDA2 in peripheral blood was associated with breast cancer susceptibility [38]. This evidence concerns the gene PHLDA2 and breast carcinoma.